OMWaNA Operationalising kangaroo Mother care before stabilisation among low birth Weight Neonates in Africa: RCT to examine mortality impact in Uganda

Lead Research Organisation: London Sch of Hygiene and Trop Medicine
Department Name: Epidemiology and Population Health

Abstract

Globally, there are 2.6 million neonatal deaths each year (defined as death during the first 28 days) and over 80% of these deaths occur in babies who are born small, due to being born too soon (preterm), being too small for their gestational age, or both. Preterm birth complications are the most common cause of death for children under age five worldwide, and yet there has been much slower progress in reducing these deaths compared to child deaths from malaria or HIV. Three-quarters of deaths due to prematurity occur in sub-Saharan Africa and south Asia, where there is limited availability of neonatal intensive care and most hospitals lack basic equipment. In Uganda alone, an estimated 45,000 newborn deaths occur annually, at least a quarter of which are directly due to complications of prematurity.

Kangaroo Mother Care (KMC) involves placing the baby skin-to-skin with a caregiver, usually the mother, promoting warmth and breastfeeding and also empowering the mother, increasing maternal confidence to improve bonding with the baby. KMC has been found to reduce deaths by 40% for newborns weighing less than 2000g, but these trials included only babies that were considered to be stable. WHO guidelines recommend KMC for babies weighing 2000g or less at birth, starting as soon as they are 'stable,' i.e., not on any other medical treatments. However, the majority of deaths occur in babies before they have stabilised, with complications like breathing difficulties, soon after birth and in settings without neonatal intensive care. The only randomised controlled trial of KMC on survival amongst babies before stabilisation reported a 43% mortality reduction compared to standard care (incubators). Importantly, this trial excluded over half of eligible babies and had other design problems. Hence, there is currently not enough evidence to recommend KMC for small babies before stabilisation who could benefit the most. A well-designed trial is needed to assess the impact of KMC started before stabilisation on mortality compared to incubator care.

The Operationalising kangaroo Mother care before stabilisation among low birth Weight Neonates in Africa (OMWaNA) trial is a partnership of the Medical Research Council Uganda, Makerere University, and the London School of Hygiene and Tropical Medicine. Omwana means 'child' in Uganda's national language. The aim of this trial is to determine the impact of KMC, started before stabilisation, on mortality (at 7 and 28 days) compared to incubator care in a group of babies weighing 2000g or less. In the trial, 2188 babies who are not yet stable will be assigned by chance to receive either KMC or incubator care. The trial will take place in four "typical" hospitals without intensive care (Jinja, Masaka, Iganga, Entebbe). Incubators are the standard method of keeping small and preterm babies warm in Ugandan hospitals, often with several newborns sharing. The trial will also compare the overall costs of KMC and incubator care, considering both costs to hospitals and costs to families. With parents and hospital staff, we will evaluate issues that support or discourage starting KMC before stabilisation. In addition, we will measure quality of life among women caring for small babies in Uganda with a new survey tool.

The Ugandan Government committed to meeting an ambitious global goal for newborn survival and has given high priority to addressing newborn deaths. The National Newborn Steering Committee has recommended increased scale-up of KMC in health facilities. Key stakeholders will be engaged throughout the trial including the Uganda Ministry of Health, Uganda Paediatric Association, UNICEF (headquarters and country), WHO, and the International KMC Network. The findings of this trial will help inform wider use of KMC in Uganda and around the world, especially in settings where most babies die, and where neonatal intensive care is not available.

Technical Summary

Globally, there are 2.6 million neonatal deaths annually. Over 80% of these occur in neonates who are small at birth. Kangaroo Mother Care (KMC) involves placing a preterm/low birthweight neonate skin-to-skin with a caregiver. A Cochrane review reported 40% mortality reduction with KMC in stable neonates. The WHO recommends KMC for routine care of newborns 2000g or less, initiated when clinically stable; yet, estimates suggest at least 75% of neonatal deaths occur before stabilisation in settings without intensive care. The only RCT of KMC before stabilisation (Ethiopia, 123 neonates) reported major mortality impact (RR 0.57) but had design challenges.

The Operationalising kangaroo Mother care before stabilisation among low birth Weight Neonates in Africa (OMWaNA) trial is a partnership of MRC/UVRI, LSHTM and Makerere University. The trial will be conducted in four Ugandan hospitals without intensive care (Jinja, Masaka, Iganga, Entebbe). We will undertake an individually randomised, controlled, superiority trial with two parallel groups to determine the effect of KMC initiated before stabilisation on mortality at 7 and 28 days relative to incubator care among 2188 neonates 2000g or less. Secondary outcomes include length of stay, weight gain, and underlying mechanisms by which KMC may influence mortality (e.g., temperature instability, apnoea, oxygen desaturation, intraventricular haemorrhage).

The economic evaluation will estimate the incremental costs and cost-effectiveness of KMC relative to incubator care from the provider, household, and societal perspectives, and model the total cost of scaling up KMC nationally. We will also utilise a novel tool to assess women's well-being, qualitatively explore enablers and barriers to implementation, and conduct a process evaluation of KMC initiation before stabilisation. Key stakeholders engaged include the Ugandan Ministry of Health, Uganda Paediatric Association, UNICEF, WHO, and the International KMC Network.

Planned Impact

The OMWaNA trial findings have potential for major impact on newborn survival and child health. Preterm birth is the leading cause of both neonatal and under-five child deaths, and over 80% of neonatal deaths occur in those who are small at birth. Estimates suggest at least 75% of neonatal deaths occur before stabilisation in settings without intensive care. If KMC is shown to be effective in reducing mortality in this population, for example by ~25% as applied in our sample size, then the number of lives saved could be 3-fold the number of child deaths due to HIV. Alternatively, if KMC is found not to be effective, it would highlight the need for more investment in technological innovations for newborn care in low-resource settings. The trial includes an economic evaluation, which will inform health system decision-making as well as capture broader benefits of KMC relative to incubator care among mothers using a novel women's well-being score. Qualitative evaluations throughout the trial will consider barriers and facilitators, which are key for wider uptake and sustainability.

Even at this early stage, key stakeholders are involved and enthusiastic, notably:

1) National level: Uganda's Ministry of Health, particularly the Newborn Steering Committee, and Uganda Paediatric Association (UPA) have demonstrated an active interest in the trial, with the latter represented on the Trial Steering Committee (TSC). Findings from the economic and qualitative aims will impact on current programmatic questions for implementation and sustainability. Estimation of the incremental cost-effectiveness of KMC relative to incubator care will inform running costs at facilities as well as district programme planning. [Letter of support: UPA]

2) International level: UNICEF and the International Kangaroo Mother Care Network have been involved in trial design and both are represented on the TSC. The Kangaroo Acceleration Partnership in which Prof Lawn (PI) and Dr Morgan (Co-PI) are engaged is also involved. The WHO guideline for preterm care highlighted key gaps in evidence regarding KMC before stabilisation, including clear criteria for stability and optimal timing and duration to improve health outcomes. Prof Lawn sits on this WHO review committee; thus, trial results will allow this influential guideline to be updated with robust evidence. [Letters of support: UNICEF, International Kangaroo Mother Care Network, TSC Chair]

3) Clinical care: Standardised KMC and other clinical care guidelines, plus the training tools developed and refined during the trial, may have an important impact on promoting provider competency and improving facility-based care of small, sick newborns in low-resource settings in collaboration with the UN's Every Newborn Action Plan. [Letter of support: UNICEF]

4) Future science and understanding pathways of effect: A further impact would be greater scientific understanding of physiological mechanisms by which KMC may influence mortality, including improved thermal control and autonomic stability, reduced apnoea, and decreased intraventricular haemorrhage. Such an understanding could inform how to reduce long-term disability risk as well as innovations for more targeted delivery of the intervention, with wider implications for neonatal care. [Letter of support: TSC Chair]

5) Local clinical and research capacity: Newborn clinical research capacity will be strengthened at MRC/UVRI and the four hospitals, facilitating further trials. Study paediatricians and medical officers will receive training in clinical trial methods and implementation, and will benefit from authorship, short courses, PhDs, and other opportunities. [Letters of support: MRC/UVRI, Hospital Directors, UPA]

Publications

10 25 50

publication icon
Kohli-Lynch M (2019) Early Intervention for Children at High Risk of Developmental Disability in Low- and Middle-Income Countries: A Narrative Review. in International journal of environmental research and public health

publication icon
Lee AC (2019) Small babies, big numbers: global estimates of preterm birth. in The Lancet. Global health

publication icon
Lee SK (2020) Neonatal risk adjustment in low-resource settings. in The Lancet. Child & adolescent health

publication icon
Manikam L (2021) Online community engagement in response to COVID-19 pandemic. in Health expectations : an international journal of public participation in health care and health policy

publication icon
Medvedev M (2020) Management of mother-newborn dyads in the COVID-19 era in The Lancet Child & Adolescent Health

 
Description Presentation about novel mortality risk score at RCPCH National Neonatal Audit Programme/Neonatal Data Analysis Unit Collaborators' Meeting
Geographic Reach National 
Policy Influence Type Influenced training of practitioners or researchers
URL https://www.rcpch.ac.uk/news-events/events/nnap-ndau-collaborators-meeting-2020
 
Description Funding for PhD fees for Victor Tumukunde
Amount £3,900 (GBP)
Organisation London School of Hygiene and Tropical Medicine (LSHTM) 
Sector Academic/University
Country United Kingdom
Start 01/2020 
End 12/2023
 
Description Postdoctoral Fellowship in Biodesign Innovation
Amount $52,800 (USD)
Organisation Stanford University 
Sector Academic/University
Country United States
Start 08/2018 
End 06/2019
 
Description Preterm Birth Initiative Postdoctoral Fellowship incl. funds for Melissa Medvedev PhD at London School of Hygiene & Tropical Medicine
Amount $92,500 (USD)
Organisation University of California, San Francisco 
Sector Academic/University
Country United States
Start 07/2015 
End 04/2020
 
Description The OMWaNA Study: Operationalizing kangaroo Mother care among clinically unstable low birth Weight Neonates in Africa
Amount $947,526 (USD)
Funding ID 1K23HD092611-01A1 
Organisation National Institutes of Health (NIH) 
Department Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)
Sector Public
Country United States
Start 06/2019 
End 05/2024
 
Description Development of NMR-2000 risk score in collaboration with Neonatal Data Analysis Unit 
Organisation Imperial College London
Department Faculty of Medicine
Country United Kingdom 
Sector Academic/University 
PI Contribution We led a study focused on developing and validating a risk score to predict in-hospital mortality among newborns weighing =2000g, which is feasible for use in high-resource and low-resource settings. We wrote the study protocol; obtained ethical approvals; conducted the literature review of neonatal risk scores; supervised collection of data from The Gambia; conducted all analyses; and drafted the manuscript.
Collaborator Contribution Our colleagues at the Neonatal Data Analysis Unit assisted with developing the protocol, obtaining National Health Service and Health Research Authority ethical approvals, and curating data from the National Neonatal Research Database. In addition, they provided periodic assistance throughout the analysis phase and helpful input during manuscript preparation/revision.
Impact 1.) DOI: 10.1016/S2352-4642(20)30021-3; PMID: 32119841. 2.) DOI: 10.1016/S2352-4642(20)30039-0; PMID: 32119842. 3.) Presentation about novel mortality risk score at RCPCH National Neonatal Audit Programme/Neonatal Data Analysis Unit Collaborators' Meeting. This multidisciplinary collaboration involves neonatal clinicians from the UK, the US, and The Gambia; statistical experts from the UK; and a health systems researcher from Uganda.
Start Year 2019
 
Description East-West African KMC trial partnership (OMWaNA & eKMC) 
Organisation Medical Research Council (MRC)
Department MRC Unit, The Gambia
Country Gambia 
Sector Public 
PI Contribution Senior investigators from OMWaNA contributed to the development of the eKMC trial protocol. The OMWaNA social sciences team provided technical expertise to eKMC investigators on the social sciences and economic evaluation of effect of kangaroo mother care on mothers and families. This will form the basis for potential future collaborations between eKMC and OMWaNA trials with options for data pooling. Funding is being sought to formalise and expand this partnership.
Collaborator Contribution The eKMC PI gave technical input to the OMWaNA trial protocol, shared eKMC standard operating procedures and contributed to team training during the OMWaNA implementation workshop (Entebbe, Aug 2019).
Impact 1.) DOI: 10.1186/s13063-019-4044-6; PMID: 32005286. 2.) DOI: 10.1186/s13063-020-4149-y. 3.) Blog about OMWaNA and eKMC trials for Healthy Newborn Network and LSHTM MARCH Centre websites. This collaboration is multi-disciplinary, with involvement of neonatal and paediatric clinicians, social scientists, health economists, and clinical trials teams.
Start Year 2019
 
Description Health facility assessments with NEST360° 
Organisation Rice University
Department Department of Bioengineering
Country United States 
Sector Academic/University 
PI Contribution In collaboration with the NEST 360° initiative, we have undertaken health facility assessments at the four OMWaNA trial hospitals to evaluate readiness for the care of small and sick newborns. These assessments encompass the following areas: • Infrastructure for neonatal care, including neonatal unit space, kangaroo mother care resources, water and electrical supply, and infection control • Physical resources for neonatal care, including supplies, medications, laboratory capacity, and essential devices and equipment • Human resource issues, including facility policies and working conditions, neonatal unit staffing, clinical care guidelines, and supervisory support and motivation • Health information systems, including sources and quality of neonatal care data
Collaborator Contribution Our colleagues at NEST 360° developed the tools used to assess facility readiness for neonatal care. In addition, the NEST 360° team led a Health Facilities Assessment Training in Nairobi in December 2019 with participants from Kenya, Malawi and Uganda, including OMWaNA trial staff.
Impact Health Facility Assessments Training in December 2019. This multi-disciplinary collaboration includes neonatal clinicians, biomedical engineers, technicians, health systems experts, and individuals with expertise in business modelling and product development.
Start Year 2019
 
Description Validation of NMR-2000 risk score with MRC Unit The Gambia 
Organisation Medical Research Council (MRC)
Department MRC Unit, The Gambia
Country Gambia 
Sector Public 
PI Contribution We led a study focused on developing and validating a risk score to predict in-hospital mortality among newborns weighing =2000g, which is feasible for use in high-resource and low-resource settings. We wrote the study protocol; obtained ethical approvals; conducted the literature review of neonatal risk scores; supervised collection of data from The Gambia; conducted all analyses; and drafted the manuscript.
Collaborator Contribution Our colleagues at MRC Unit The Gambia assisted with obtaining local ethical approvals, collected Gambian validation data, and provided helpful input during manuscript writing/revision.
Impact 1.) DOI: 10.1016/S2352-4642(20)30021-3; PMID: 32119841. 2.) DOI: 10.1016/S2352-4642(20)30039-0; PMID: 32119842. 3.) Presentation about novel mortality risk score at RCPCH National Neonatal Audit Programme/Neonatal Data Analysis Unit Collaborators' Meeting. This multidisciplinary collaboration involves neonatal and paediatric clinicians from the UK, the US, and The Gambia; statisticians and clinical trial experts from the UK; and health systems researchers from the UK and Uganda.
Start Year 2019
 
Description Blog about OMWaNA and eKMC trials for Healthy Newborn Network and LSHTM MARCH Centre websites 
Form Of Engagement Activity Engagement focused website, blog or social media channel
Part Of Official Scheme? No
Geographic Reach International
Primary Audience Media (as a channel to the public)
Results and Impact Co-wrote a blog for World Prematurity Day (November 2019) entitled, "Kangaroo mother care: providing the right care, at the right time, in the right place for babies born too soon," which was published on the websites of the MARCH Centre at LSHTM and the Healthy Newborn Network of the Saving Newborn Lives programme, Save the Children Federation (URL below). The blog discusses the implementation experiences of the OMWaNA trial in Uganda and the Early KMC (eKMC) trial in The Gambia.
Year(s) Of Engagement Activity 2019
URL https://www.healthynewbornnetwork.org/blog/kangaroo-mother-care-an-effective-intervention-to-provide...
 
Description Health Facilities Assessment Training in December 2019 
Form Of Engagement Activity Participation in an activity, workshop or similar
Part Of Official Scheme? No
Geographic Reach International
Primary Audience Professional Practitioners
Results and Impact In collaboration with our colleagues at the NEST 360° initiative, the OMWaNA trial team participated in a Health Facilities Assessment Training in Nairobi in December 2019, which included participants from Kenya, Malawi, and Uganda.
Year(s) Of Engagement Activity 2019
URL https://www.nest360.org/
 
Description Interview for a national newspaper in Uganda - The New Vision - on the launch of the OMWaNA Trials 
Form Of Engagement Activity A press release, press conference or response to a media enquiry/interview
Part Of Official Scheme? No
Geographic Reach National
Primary Audience Public/other audiences
Results and Impact Interview with national newspaper resulting in a feature article and photograph in the New Vision (Ugandas leading national newspaper) highlighting the importance of preterm birth and related mortality and sharing information on the launch of the OMWaNA trial and potential impact.
Year(s) Of Engagement Activity 2019
URL https://www.newvision.co.ug/new_vision/news/1506289/kangaroo-mother-care-clinical-study-launched
 
Description Launch of the OMWaNA trial 
Form Of Engagement Activity Participation in an activity, workshop or similar
Part Of Official Scheme? No
Geographic Reach National
Primary Audience Policymakers/politicians
Results and Impact Public launch of the trial with Uganda Ministry of health 3 senior people, Director of MRC Uganda, and media from 4 TV crews and several newspapers including New Vision
Speeches by Ministry of health, Joy Lawn, Ugandan Paediatric President, and the 4 Hospital Directors as well as MRC Uganda Director.
Year(s) Of Engagement Activity 2019
URL https://www.mrcuganda.org/news/uganda-leading-groundbreaking-research-newborn-deaths-hospitals